Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Comparison of Oral Montelukast and Intranasal Fluticasone in Patients with Asthma and Allergic Rhinitis.

Jindal A, Suriyan S, Sagadevan S, Narasimhan M, Shanmuganathan A, Vallabhaneni V, Rajalingam R.

J Clin Diagn Res. 2016 Aug;10(8):OC06-10. doi: 10.7860/JCDR/2016/20741.8268. Epub 2016 Aug 1.

2.

Leukotriene-receptor antagonists versus placebo in the treatment of asthma in adults and adolescents: a systematic review and meta-analysis.

Miligkos M, Bannuru RR, Alkofide H, Kher SR, Schmid CH, Balk EM.

Ann Intern Med. 2015 Nov 17;163(10):756-67. doi: 10.7326/M15-1059. Epub 2015 Sep 22. Review.

3.

Nasobronchial interaction.

Cingi C, Muluk NB, Cobanoglu B, Çatli T, Dikici O.

World J Clin Cases. 2015 Jun 16;3(6):499-503. doi: 10.12998/wjcc.v3.i6.499. Review.

4.

Reply: To PMID 25174863.

Dixon AE, Castro M, Cohen RI, Gerald LB, Holbrook JT, Irvin CG, Mohapatra S, Peters SP, Rayapudi S, Sugar EA, Wise RA; American Lung Association–Asthma Clinical Research Centers.

J Allergy Clin Immunol. 2015 Jul;136(1):212-3. doi: 10.1016/j.jaci.2015.04.003. Epub 2015 May 8. No abstract available.

5.

Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma.

American Lung Association–Asthma Clinical Research Centers' Writing Committee, Dixon AE, Castro M, Cohen RI, Gerald LB, Holbrook JT, Irvin CG, Mohapatra S, Peters SP, Rayapudi S, Sugar EA, Wise RA.

J Allergy Clin Immunol. 2015 Mar;135(3):701-9.e5. doi: 10.1016/j.jaci.2014.06.038. Epub 2014 Aug 28.

6.

The effect of combined medical treatment on quality of life in persistent allergic rhinitis.

Tatar EÇ, Sürenoğlu UA, Ozdek A, Saylam G, Korkmaz H.

Indian J Otolaryngol Head Neck Surg. 2013 Aug;65(Suppl 2):333-7. doi: 10.1007/s12070-012-0486-9. Epub 2012 Feb 2.

7.

Managing co-morbid asthma with allergic rhinitis: targeting the one-airway with leukotriene receptor antagonists.

Valovirta E.

World Allergy Organ J. 2012 Apr;5(Suppl 3):S210-1. doi: 10.1097/WOX.0b013e3181f4ea72. Epub 2012 Apr 17.

8.

Nose and lungs: one way, one disease.

Caimmi D, Marseglia A, Pieri G, Benzo S, Bosa L, Caimmi S.

Ital J Pediatr. 2012 Oct 25;38:60. doi: 10.1186/1824-7288-38-60. Review.

9.

Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.

Chauhan BF, Ducharme FM.

Cochrane Database Syst Rev. 2012 May 16;(5):CD002314. doi: 10.1002/14651858.CD002314.pub3. Review.

10.

Hay fever in adolescents and adults.

Sheikh A, Singh Panesar S, Salvilla S, Dhami S.

BMJ Clin Evid. 2009 Nov 18;2009. pii: 0509. Review.

11.

The role of inhaled and/or nasal corticosteroids on the bronchodilator response.

Lee JK, Suh DI, Koh YY.

Korean J Pediatr. 2010 Nov;53(11):951-6. doi: 10.3345/kjp.2010.53.11.951. Epub 2010 Nov 30.

12.

Treatment of congestion in upper respiratory diseases.

Meltzer EO, Caballero F, Fromer LM, Krouse JH, Scadding G.

Int J Gen Med. 2010 Apr 8;3:69-91.

13.

Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children.

Ni Chroinin M, Lasserson TJ, Greenstone I, Ducharme FM.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007949. doi: 10.1002/14651858.CD007949. Review. Update in: Cochrane Database Syst Rev. 2015;11:CD007949.

14.

Rates of asthma attacks in patients with previously inadequately controlled mild asthma treated in clinical practice with combination drug therapy: an exploratory post-hoc analysis.

Dal Negro RW, Borderias L, Zhang Q, Fan T, Sazonov V, Guilera M, Taylor SD.

BMC Pulm Med. 2009 Mar 30;9:10. doi: 10.1186/1471-2466-9-10.

15.

Rhinosinusitis and asthma: the missing link.

Dixon AE.

Curr Opin Pulm Med. 2009 Jan;15(1):19-24. doi: 10.1097/MCP.0b013e32831da87e. Review.

16.

Allergic rhinitis: evidence for impact on asthma.

Thomas M.

BMC Pulm Med. 2006 Nov 30;6 Suppl 1:S4. Review.

Supplemental Content

Support Center